Imaging modality of choice to localize Neuroendocrine tumors?
USG
CT
MRI
Somatostatin receptor scintigraphy
Imaging modality of choice to localize Neuroendocrine tumors is Somatostatin receptor scintigraphy. Whole body planar images (A) of a 99m Tc HYNIC TOC study of a recently detected case of pancreatic NET reveals the uptake in the primary (arrow) and the metastatic lesions which are localized on the transaxial SPECT/CT images to correlate with the lesion in the skull (B), a enlarged prevascular node (C) and a tiny pleural based pulmonary nodule (D) which is identified on the correlative CT image (triangulated in E). Another pulmonary nodule is seen as a focus of uptake in the left hemithorax on the whole body planar image (A).
Neuroradiology